GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (BOM:530019) » Definitions » Price-to-Free-Cash-Flow

Jubilant Pharmova (BOM:530019) Price-to-Free-Cash-Flow : N/A (As of Jun. 19, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Jubilant Pharmova Price-to-Free-Cash-Flow?

As of today (2024-06-19), Jubilant Pharmova's share price is ₹729.90. Jubilant Pharmova's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Hence, Jubilant Pharmova's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Jubilant Pharmova's Price-to-Free-Cash-Flow or its related term are showing as below:

BOM:530019' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 5.28   Max: 164.28
Current: 157.34

During the past 13 years, Jubilant Pharmova's highest Price-to-Free-Cash-Flow Ratio was 164.28. The lowest was 0.00. And the median was 5.28.

BOM:530019's Price-to-Free-Cash-Flow is ranked worse than
92.21% of 526 companies
in the Drug Manufacturers industry
Industry Median: 22.88 vs BOM:530019: 157.34

Jubilant Pharmova's Free Cash Flow per Share for the three months ended in Mar. 2024 was ₹0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₹0.00.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -61.10% per year.

During the past 13 years, Jubilant Pharmova's highest 3-Year average Free Cash Flow per Share Growth Rate was 64.00% per year. The lowest was -61.10% per year. And the median was 15.10% per year.


Jubilant Pharmova Price-to-Free-Cash-Flow Historical Data

The historical data trend for Jubilant Pharmova's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jubilant Pharmova Price-to-Free-Cash-Flow Chart

Jubilant Pharmova Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.06 8.62 25.98 - 122.55

Jubilant Pharmova Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 122.55

Competitive Comparison of Jubilant Pharmova's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Jubilant Pharmova's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jubilant Pharmova's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jubilant Pharmova's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Jubilant Pharmova's Price-to-Free-Cash-Flow falls into.



Jubilant Pharmova Price-to-Free-Cash-Flow Calculation

Jubilant Pharmova's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=729.90/0
=N/A

Jubilant Pharmova's Share Price of today is ₹729.90.
Jubilant Pharmova's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Jubilant Pharmova  (BOM:530019) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Jubilant Pharmova Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Jubilant Pharmova's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Jubilant Pharmova (BOM:530019) Business Description

Traded in Other Exchanges
Address
1A, Sector 16A, Noida, UP, IND, 201 301
Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.

Jubilant Pharmova (BOM:530019) Headlines

No Headlines